Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

Clinical trial NCT01147939 · COMPLETED

Trial details

NCT number: NCT01147939
Sponsor: Clavis Pharma
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Myeloid Leukemia (AML)

Start date: 2010-06-01
Primary completion: 2013-02-01
Enrollment: 381

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.